IP Library Granted Patent US 9,663,816
Granted Patent B2
US 9,663,816 · App. 14/391,885 · Granted May 30, 2017

Method for measuring a component of a biological fluid and reducing the effect of interfering substances

Inventors: Hideyuki Kuwata (Sunto-gun, JP); Tomoko Aratake (Sunto-gun, JP); Kenta Kinjo (Sunto-gun, JP)
Assignee: KYOWA MEDEX CO., LTD.
C12Q1/28C09B21/00G01N33/581G01N33/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,663,816
App. No.
14/391,885
Granted
May 30, 2017
Kind
B2
Abstract

Provided is a measuring method of a component to be measured in a specimen while suppressing an influence of bilirubin. A measuring method of a component to be measured, comprising converting the component to be measured in the specimen to hydrogen peroxide through an enzymatic reaction, reacting the formed hydrogen peroxide with an oxidative-coloring chromogen in the presence of a peroxidase, and measuring an absorbance of the colored reaction solution to thereby determine the component to be measured, wherein a fatty acid or a salt thereof coexists. The measuring method of a component to be measured in a specimen according to the present invention is useful in clinical diagnosis.

Claims (9)

1. A measuring method of a component to be measured in a specimen, comprising the steps of:

adding a fatty acid or a salt thereof to an aqueous solution containing the specimen;

converting the component to hydrogen peroxide through an enzymatic reaction;

reacting the formed hydrogen peroxide with an oxidative-coloring chromogen in the presence of a peroxidase; and

measuring an absorbance of the colored reaction solution to thereby determine the component, wherein

the component is selected from the group consisting of total cholesterol (TC), cholesterol in high-density-lipoprotein (HDL-C), cholesterol in low-density lipoprotein (LDL-C), cholesterol in very-low-density lipoprotein (VLDL-C), cholesterol in remnant-like lipoprotein (RLP-C), glucose, uric acid, triglycerides (TG), phospholipids, choline, creatine, creatinine, lactic acid, and pyruvic acid, and

the fatty acid or a salt thereof coexists.

2. The measuring method according to claim 1 , wherein the fatty acid is a saturated or unsaturated fatty acid having 8 to 24 carbon atoms.

3. The measuring method according to claim 2 , wherein the fatty acid is selected from the group consisting of octanoic acid, decanoic acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, eicosatrienoic acid, arachidonic acid, icosanoic acid, eicosatetraenoic acid, eicosapentaenoic acid, docosanoic acid, docosahexaenoic acid, tetradocosanoic acid, and tetracosapentaenoic acid.

Assignments (4)
CHANGE OF NAME Recorded Sep 23, 2025
From: KYOWA MEDEX CO., LTD.
To: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
Reel/Frame 072925/0508 →
CHANGE OF NAME Recorded Sep 23, 2025
From: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
To: MINARIS MEDICAL CO., LTD.
Reel/Frame 072925/0657 →
CHANGE OF NAME Recorded Sep 23, 2025
From: MINARIS MEDICAL CO., LTD.
To: CANON MEDICAL DIAGNOSTICS CORPORATION
Reel/Frame 072925/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2014
From: KUWATA, HIDEYUKI; ARATAKE, TOMOKO; KINJO, KENTA
To: KYOWA MEDEX CO., LTD.
Reel/Frame 033930/0914 →
Priority Claims (2)
JP 2012-103258 · Apr 27, 2012 · national
JP 2012-119584 · May 25, 2012 · national
Continuity (1)
Related Publication 20150079620A1 · Mar 19, 2015